EFCG membership is open to all European manufacturers of fine chemicals and those who represent them.
The company membership is as follows:
Albemarle (B), Allessa (D), AlzChem AG (D), BASF (NO), Borregaard (N0),Bracco Imaging (I), Briar Chemicals (UK), CABB (DE), Calachem Ltd. (UK), Cerbios Pharma (CH), CU Chemie Uetikon (D), Contract Chemicals (UK), Derivados Quimicos (IT), Dipharma (IT), ESIM Chemicals (A), Euticals SpA (IT), Evonik (D),Fabbrica Italiana Sintetici (IT), Grace (D),Helsinn (CH), Hovione (PT),Lonza (CH), Ashland (UK), Medichem (ES), Merck KGaA (D), PCAS (F), Robinson Brothers(UK), Saltigo (D), Schirm (D), Seratec (F), Siegfried (CH), Solvay (F), Vertellus (UK), WeylChem (D)
Typically, company representatives are either the CEO or similar senior level people who actually run businesses and companies, hands on and at the sharp end.
EFCG enjoys a privileged relationship with APIC – the Active Pharmaceutical Ingredients Committee – another Cefic sector group, that acts as the technical voice of the API industry in the standard-setting process. APIC has 2 seats on the EFCG Board.
Altogether, EFCG speaks for over 300 fine chemical sites across Europe, over half of which are dedicated to the pharmaceutical industry.
Membership fees are set annually at the General Assembly of all members. Members must also be members of CEFIC to whom they must pay an additional annual fee. For further information and to be sent membership application forms, email firstname.lastname@example.org .
In 2004 EFCG raised the first red flags about sub-standard Active Pharmaceutical Ingredients (APIs) entering Europe from India and China. Twelve years on, it appears that risks to patients from non-compliant bad quality APIs have been substantially reduced and that the playing field is levelling out.
EFCG Press Conference CPhI 2015: "API" day for Europe as Big Pharma returns in search of quality (by Dan Stanton)
EFCG Press Conference CPhI 2015: Outlook in Europe for API Manufacturers is positive, says EFCG